A recent meta‐analysis of seven published trials on the use of an add‐on ketogenic diet in people with Dravet syndrome (of which 80–100% had an SCN1A mutation) revealed good efficacy of this treatment (Wang et al., 2020). The gene discussed is SCN1A; the disease is Dravet syndrome.